Rhythm Pharmaceuticals

• The global cardiovascular-kidney-liver-metabolic burden from 1990 to 2023

  Fees or honoraria, 22 Aug 2026

• Socioeconomic position, genetic susceptibility, and epigenetic profiles in obesity across the life course: a systematic review

  Fees or honoraria, Grants or research support, 3 Aug 2026

• Blood-brain barrier water permeability is elevated in type 2 diabetes and obesity: associations with cognitive function and metabolic markers

  Consulting or advice, 22 Jul 2026

• Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans

  Fees or honoraria, 17 Mar 2026

• European Association for the Study of Obesity Position Statement on the Diagnosis and Management of Obesity in Older Adults

  Grants or research support, 27 Nov 2025

• Vitamin D is glucoprotective in aging males but not females

  Consulting or advice, Fees or honoraria, Grants or research support, 14 Nov 2025

• The role of weight management in sleep disordered breathing

  Fees or honoraria, 16 Sept 2025

• Tirzepatide for Older Adults with Type 2 Diabetes and Without Obesity: A Post Hoc Analysis of the SURPASS Clinical Trials

  Consulting or advice, 28 Feb 2025

Sources: pubmed.ncbi.nlm.nih.gov

• Waist-to-Height Ratio Outperforms BMI in Identifying Hepatic Steatosis and Fibrosis in U.S. Adults

  ADA Scientific Sessions 2026 abstract, 6 Jun 2026

• SUN-645 Leptin- And Incretin-based Combination Therapy In Lipodystrophy: A Promising Metabolic Strategy?

  ENDO 2025 abstract, 23 Oct 2025

• Reference Values for OGTT-Derived Insulin Indices Enable Early Detection of Emerging Type 2 Diabetes in Children and Young Adults with Obesity

  ADA Scientific Sessions 2025 abstract, 13 Jun 2025

• Short-Term Reproducibility of i3C Risk Score in Predicting Cardiac Events in Young People

  ADA Scientific Sessions 2025 abstract, 13 Jun 2025